Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 21, 1999

View Archived Issues

Potential of RSVIG assessed in immunosuppressed animal model

Genzyme Molecular Oncology reports preclinical results, collaboration for aaATIII

Oxford GlycoSciences continues steady progress during first half

Peptide Therapeutics achieves significant milestones during first half of 1999

Chimeric anti-factor D MAb from Tanox for complement-mediated disorders

FDA okays new pediatric formulation of zafirlukast

New series of protein tyrosine kinase and cyclin-dependent kinase inhibitors

Schering AG announces intention to acquire Diatide

Propofol is highly effective in treating refractory migraine pain

New isomer of toremifene metabolite has favorable antiestrogenic and hypolipidemic effects

TNF-alpha inhibitor CNI-1493 ameliorates experimental arthritis in rats

Two new AIDS treatment options introduced in Germany

Yissum prepares two new glycinamide derivatives useful as anticonvulsants

Dofetilide restores sinus rhythm without increasing risk of death in patients with CHF

U.S. HHS describes new antitumor lavendustin A analogues

Inhibitors of monoamine reuptake revealed recently by U. of Minnesota

New target, new treatment for allergies and asthma discovered at Hughes Institute

Japanese coalition formed for development of new drugs

Kyowa Hakko begins clinical testing of MAb as melanoma Rx

Valentis and Boehringer Ingelheim establish gene medicine collaboration for rheumatoid arthritis

Rifalazil: preclinical and clinical results presented at IUATLD conference; development on hold

Japanese launch of nateglinide announced

Glaxo Wellcome's GW-9578 is the most potent PPARalpha agonist yet reported

Chinese study shows new Cl- transport inhibitor equieffective to corticosteroids in asthma

Unique cardioprotective profile of FR-168888 emerges from pharmacological studies

Mylan and Synthon enter strategic alliance

Switch Biotech awarded grant for wound-healing therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...